News
Paul Crocker is stepping down as Head of Cell Signalling and Immunology (CSI) after 5 years in the position.
News
Paul Crocker is stepping down as Head of Cell Signalling and Immunology (CSI) after 5 years in the position.
News
On October 1st 1969 Philip Cohen became a postdoc in Edmond Fischer’s at the University of Washington, Seattle, USA and started his research on protein phosphorylation.
Press release
An entrepreneurial scientist from the University of Dundee has proven his business concept is more than skin deep after winning one of the country’s top enterprise awards
Press release
The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).
Press release
Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Celgene